this EcoRI fragment into the higher-copy-number replicon pMB9, generating pGX300. pGX300 was digested into four fragments with HindIII and EcoRI, and the digest was self-ligated. Among the ampicillin-resistant (Apr) transformants recovered were two strains containing smaller plasmids, pGX310 and pGX311 (which each contain 3.4 kb of pI258-derived DNA). Media and reagents. The compositions of L broth and L agar (13) have been described previously. S7 is the synthetic medium of Vasantha and Freese (43) in which the morpholinepropanesulfonic acid buffer was replaced by 100 mM potassium phosphate (pH 7.0).
The analysis of the expression of genes in a heterologous host has become an important area of study for reasons of both fundamental and commercial interest. The in vitro expression of blaZ, a Staphylococcus aureus 1-lactamase gene, in a coupled transcription-translation system derived from Bacillus subtilis was demonstrated by McLaughlin et al. (24) . Our attempts to extend this result with in vivo studies were initially unsuccessful because we were not able to introduce blaZ into B. subtilis with plasmid vectors. Analysis of blaZ mutations on plasmids that were obtained from these attempts suggested that the problem in establishment was associated with the expression of blaZ. Subsequently, the technique of chromosomal integration (14, 47) was found to allow blaZ to be established in B. subtilis. The B. subtilis strains isolated in this way carry blaZ stably and express the gene efficiently. Thus, chromosomal integration appears to be a useful technique for stabilizing the inheritance of genes that are not easily established on plasmid vectors.
MATERIALS AND METHODS
Strains and plasmids. Escherichia coli HB101 (hsd-20 recA13 ara-14 proA2 lac YJ galK2 rpsL20 xyl-5 mtl-i supE44) (4) was used throughout. B. subtilis BR151 (trpC2 metB10 lys-3) (20) and 1A169 (trpC2 hisA sacB182) (Bacillus Genetic Stock Culture) were used as noted. E. coli plasmids pSC122 (42) , pMB9 (37) , and pBR322 (5) and B. subtilis vectors pE194, pC194, and pUB110 (6), have been described previously. pGX145 was constructed (D. M. Anderson and E. A. Kalk, unpublished results) by inserting the multisite linker region of pUC9 (44) as an EcoRI-HindIII fragment into pKG1816 (a derivative of pKG1800 [23] containing the A to transcriptional terminator; K. McKenney, personal communication). pGX345 was constructed by inserting a 1-kilobase (kb) MspI-MboI fragment from pC194 (18) between the ClaI and BamHI sites of pGX145; the inserted fragment contains cat, but lacks a replicon functional in B. subtilis (18) . pGX310 and pGX311 were constructed as follows: pSC122 contains a 7-kb EcoRI fragment from the S. aureus plasmid p'258 (34) , which carries blaZ. We recloned (24) this EcoRI fragment into the higher-copy-number replicon pMB9, generating pGX300. pGX300 was digested into four fragments with HindIII and EcoRI, and the digest was self-ligated. Among the ampicillin-resistant (Apr) transformants recovered were two strains containing smaller plasmids, pGX310 and pGX311 (which each contain 3.4 kb of pI258-derived DNA).
Media and reagents. The compositions of L broth and L agar (13) have been described previously. S7 is the synthetic medium of Vasantha and Freese (43) in which the morpholinepropanesulfonic acid buffer was replaced by 100 mM potassium phosphate (pH 7.0).
For plasmid preparations, M9 buffer (36) was supplemented with 0.6% Casamino Acids, 1 pg of thiamine per ml, 45 puM FeSO4, 2 mM MgSO4, and 0.2% glucose. Minicell labeling medium consisted of morpholinepropanesulfonic acid medium supplemented with amino acids, purines, pyrimidines, and vitamins as described previously (30) , with the following modifications: arginine, 6 mM; cysteine, 0.5 mM; riboflavin, 1 ,ug/ml; folate and niacin, 2 ,ug/ml; pyridine and pyridoxal, 4 ,ug/ml; biotin and pyridoxamine, 8 ,ug/ml; methionine, p-hydroxybenzoic acid, and 2,3-dihydroxybenzoic acid were omitted. Restriction endonucleases were purchased from New England Biolabs and Boehringer Mannheim and used as described by Maniatis et al. (21) . Nuclease BAL-31 was purchased from Bethesda Research Laboratories and was used according to the supplier's recommendations. Lysozyme, RNase A, proteinase K, and agarose (type II) were Analytical gel electrophoresis. Samples were electrophoresed as described by Gellert et al. (8) .
Transformation. Competent B. subtilis cells were prepared as described previously (39) , centrifuged, suspended in 0.1 volume of spent growth medium, frozen in liquid nitrogen, and stored at -80°C. For transformation, frozen competent cells were thawed quickly at 37°C and diluted with 1 to 3 volumes of medium SpC (39) . A 0.3-ml sample of cells was mixed with DNA and incubated at 37°C on a reciprocal shaker for 30 min. Samples (0.1 ml) were plated in a 2.5-ml 0.7% agar overlay on an L plate, which was incubated at 37°C for 1 h before being overlaid with an additional 2.5 ml of 0.7% agar containing chloramphenicol or kanamycin to give a final concentration in the plate of 10 pLg of chloramphenicol or kanamycin per ml.
Competent E. coli cells were prepared as described previously (21) , except that cells were treated and suspended in 100 mM CaCl2-50 mM MgCI2. Glycerol was then added to 20%, and 0.5-ml samples were frozen and stored at -80°C. Transformation was performed as described previously (21) with cells that had been thawed on ice. Transformants were selected by spreading samples on L agar containing 30 ,ug of ampicillin per ml alone or with any one of the following additions: 12.5 ,ug of tetracycline per ml, 10 ,ug of chloramphenicol per ml, or 10 ,ug of kanamycin per ml.
Preparation of plasmid DNA. Small amounts of plasmid DNA were prepared by the method of Holmes and Quigley (17) (10 mg/ml in STET) was added, and the sample was incubated for 30 min at 37°C. After boiling for 1 min and centrifuging in a microfuge for 10 min, the supernatant was removed and treated with S ,ul of proteinase K (5 mg/ml), first at 37°C for 15 min and then at 75°C for 20 min.
The DNA was precipitated with an equal volume of isopropanol and suspended in 50 pul of water.
Large amounts of plasmid DNA were prepared from B. subtilis as described previously (11) . From E. coli, large amounts of plasmid DNA were prepared by the method of Holmes and Quigley (17) . DNA prepared by either method was purified by dye-buoyant density equilibrium centrifugation as described previously (12) . After removal of the ethidium bromide, the DNA was dialyzed into 10 mM Trishydrochloride (pH 8.0)-i mM disodium EDTA.
Preparation of B. subtilis chromosomal DNA. A culture was grown at 37°C in in 100 ml of L broth to an absorbancy at 600 nm of about 0.4. The cells were spun down and suspended in 2 ml of 150 mM NaCI-100 mM EDTA, pH 8.0. A 0.25-ml sample of lysozyme (4 mg/ml in 150 mM NaCI-100 ml EDTA, pH 8.0) was added, and the sample was incubated for 25 Tris-acetate (pH 7.4)-0.5% Triton X-100-2 mM disodium EDTA-150 mM NaCl. After incubation for 15 min at room temperature, the cells were again centrifuged and suspended in the original volume of IPD-SP (3:1) buffer and stored on ice. For pretreatment of the sample, 100 plA of activated staphylococcal cells was added, and the mixture was incubated for 30 min on ice. The cells were then removed by centrifugation, and the supernatant was used for immunoprecipitation.
A 5-pA sample of antibody to staphylococcal ,-lactamase was added (50 pl of antibody precipitates 10 ,ug of ,1-lactamase; J. Nielsen, personal communication), and the mixture was incubated overnight at 4°C. A 100-pA sample of freshly activated staphylococcal cells was added, and the mixture was incubated for 30 min on ice. The cells were pelleted for 90 s in a microfuge and washed three times with IPW buffer (10 mM Tris-hydrochloride [pH 7.4] , 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.5% SDS), each time completely suspending the pellet. After the final wash, the cells were suspended in 50 ,ul of SP buffer and boiled for 5 min. The cells were removed by centrifugation, and the supernatant was saved for analysis.
For immunoprecipitation of B. subtilis extracts, cultures were grown to an absorbancy at 600 nm of 0.3 to 0.6 in S7 medium supplemented with tryptophan and lysine (50 ,ug/ml each) and methionine (5 ,ug/ml). The cells were centrifuged at room temperature and suspended in the original volume of S7 supplemented with tryptophan and lysine only (50 p.g/ml). 20 p.1 were subjected to electrophoresis on a 15% SDS-polyacrylamide gel as described previously (41) . After staining and destaining, the gel was prepared for fluorography with En3Hance (New England Nuclear Corp.). The dried gel was exposed to Kodak XAR-2 film at -80°C.
RESULTS
Inability to establish blaZ in B. subtilis on a multicopy plasmid. pGX312 and pGX314 (Fig. 1) are blaZ-containing plasmids that were designed to be shuttle vectors as they contain replicons capable of extrachromosomal maintenance in both E. coli (the pMB9 replicon) and B. subtilis (the pC194 or pUB110 replicons). However, although each plasmid could be easily established and maintained in E. coli (data not shown), no colonies containing either plasmid were recovered from attempts to transform competent cells of either of two B. subtilis strains, BR151 and 1A169 (Fig. 1). (a) Although a few kanamycin-resistant (Kmr) colonies were obtained in the experiments with pGX312, these all harbored plasmids that were considerably smaller and differed significantly in restriction pattern from the parental plasmids. In particular, blaZ did not appear to be intact in any of these transformants.
Although these results suggested that some shuttle vectors based upon pGX311 could not be established in B. subtilis, fragments comprising most of pGX311 could be established in that host. Figure 2 outlines two experiments; in each, pGX311 was digested with two restriction enzymes to generate a pair of fragments. Attempts were then made to clone each fragment. However, only one fragment of the pair was recovered in transformants in each instance (Fig. 2) . The only region of pGX311 that was not established on vector pUB110 was the 1.2-kb segment extending from the BamHI site to the XbaI site (Fig. 2b) , a region which includes the promoter and 5' end of blaZ.
Inability to establish promoter-bearing fragments of blaZ on a multicopy plasmid in B. subtilis. The previous results suggested that the 5' end of blaZ may have been involved in preventing the inheritance in B. subtilis of plasmids carrying blaZ. Further evidence in support of this hypothesis came from experiments with pGX318 (Fig. 3) , a pC194-based shuttle vector that contains only a small region of the 5' end of blaZ. In two different transformation experiments with B. subtilis as a recipient, no colonies containing pGX318 were recovered. In one experiment, the plasmids from the six transformants appeared to be similar to one another, but different from pGX318 in that they contained an 800-basepair insertion in the blaZ promoter region (Fig. 3) . By its size and the presence of single PstI and PvuII recognition sites (data not shown), the insert appeared to be ISJ (35; the ISJ insertion presumably occurred during passage of pGX318 in E. coli; see below).
In another experiment, in which a different preparation of pGX318 was used for transformation, five chloramphenicolresistant (Cmr) transformants were analyzed. Plasmids in four of these were found to have large deletions in the blaZ region; the fifth plasmid (designated pGX328) contained a small deletion. DNA sequence analysis of pGX328 revealed that there was a'31-base-pair deletion (designated AblaZ31) in the blaZ promoter region (Fig. 4) . This deletion removed the -10 region of the blaZ promoter and the site of initiation of transcription (25) .
As implied by its stability and in contrast to pGX318, pGX328 was able to transform B. subtilis. With competent BR151 cells and with 1 pg of DNA per ml in the transformation tube, 510 Cmr transformants per 0.1 ml of culture were obtained with pGX328; under the same conditions, pGX318 generated only 10 Cmr transformants per 0.1 ml (the plasmids in these few Cmr transformants had suffered rearrangements, as noted above). Thus, although we have been unable to establish pGX318 in B. subtilis, we have isolated two derivatives of it which readily transform this host. As both derivatives contained alterations in the promoter region of blaZ, we conclude that this region of the gene is responsible for the inability of pGX318, and presumably other blaZcontaining plasmids, to transform B. subtilis.
Integration of blaZ into the B. subtilis chromosome. In contrast to our inability to isolate a B. subtilis strain carrying blaZ on a plasmid, we were readily able to isolate B. subtilis strains that stably carried blaZ integrated into the chromo- 4 . DNA sequence of the 5' nontranslated regions of blaZ in pGX318 and pGX328. The DNA sequence of this region in pGX318 was determined and found to be identical to the sequence presented by McLaughlin et al. (25) . Several features identified by these authors are indicated: the -35 and -10 regions are indicated in large bold type, the site of transcription initiation is indicated by an arrow, the ShineDalgarno sequence is denoted with italicized type, and the TTG initiation codon is underlined. Note that the sequence deleted from pGX318 is flanked by an 8-base-pair direct repeat, which is part of a larger ( Fig. 1 and 2 ; also N, NruI; XhoI; Bg, BglI; (N/P), a fused half NruI and PvuII site that i' longer recognized by either enzyme. some. pGX281 (Fig. 5) A bIaZ-containing fragment from pGX310 (Fig. 5) was inserted into pGX281 in each of two orientations, generating pGX2413 and pGX2414, respectively. In addition to blaZ, both of these plasmids also carry the amp gene of pBR322 (Fig. 5) . Consequently pGX2423, a plasmid carrying blaZ but not amp, was also constructed (Fig. 5) as a control.
Cmr transformants were obtained from transformation of BR151 with pGX281 and its blaZ-carrying derivatives pGX2413, pGX2414, and pGX2423 ( Table 1 ). Transformants that arose from those plasmids containing blaZ producedlactamase (Table 1) . This Bla+ phenotype must be due to the presence and expression of blaZ rather than of amp, because (i) transformants generated from pGX2423, which carries blaZ but lacks most of amp, were Bla+; and (ii) pGX281, which contains amp but not blaZ, did not produce Bla+ transformants. Furthermore, removal of the blaZ-containing EcoRI fragment of pGX2413, which generated the plasmid pGX2434 (Fig. 5) transferred by patching daily onto drug-free L agar for 6 to 10 days, after which samples were streaked onto drug-free L agar. Single colonies were then picked onto L agar with and without chloramphenicol (10 p.g/ml) and tested for chloramphenicol resistance and P-lactamase production. ' A colony of each transformant was inoculated into L broth and subcultured for a total of 30 generations. Samples were then streaked on L agar, and single colonies were scored for chloramphenicol resistance and f3-lactamase production.
demonstrate that blaZ was stably inherited by strains carrying an integrated vector.
Location of vector DNA in B. subtilis transformants. To confirm that blaZ was integrated into the chromosome of the stable transformants and to analyze the structure of the integrated vector, cellular DNA from several transformants was examined by gel transfer hybridization (45) . With 32p-labeled, linearized pGX2413 as a probe, DNA from strains GX2499, GX2498, and GX2497 (generated by transformation with pGX281, pGX2413, and pGX2414, respectively) was studied. The hybridization patterns of DNA digested with a number of restriction enzymes (Table 3) were consistent with the hypothesis that, in each case, a single copy of the entire plasmid had integrated at the site of homology between the chromosome and plasmid. No (Fig. 6 ). This band was Absent in an extract of the Bla-strain GX2499 (Fig. 6 ). On the basis of a comparison of the number of immunoprecipitable counts obtained from GX2492 and GX2499, we estimated that about 1% of the trichloroacetic acid-insoluble counts (total incorporation into protein) was specifically immunoprecipitable with the anti-1-lactamase antibodies. Most of the immunoprecipitable material from B. subtilis was cell associated (Fig. 6) .
In an E. coli strain carrying blaZ on pGX271, the immunoprecipitable counts were also found to represent about 1% of the total synthesis (data not shown). The immunoprecipitated material from E. coli also migrated as a 28-kilodalton protein.
Growth of B. subtilis in the presence of ampicillin. Imanaka et al. (19) (Fig. 3b) (46) in B. subtilis (data not shown). These results strongly suggest that the S. aureus blaZ promoter is active in vivo in B. subtilis.
With respect to the protein that is produced in B. subtilis, the mobility of the 35S-labeled material precipitated by the anti-S. aureus 1-lactamase serum suggested a molecular mass (28 kilodaltons) for the blaZ-specific product that is similar to that expected for an S. aureus 1-lactamase (2). However, since the S. aureus 1-lactamase is a processed lipoprotein in its native host (32) , the blaZ product made in either B. subtilis or E. coli may exist in any one of several forms, and further characterization of the protein will be necessary to determine the form(s) of staphylococcallactamase that is made in these heterologous hosts.
In S. aureus, the blaZ product is largely secreted to the extracellular medium, although about one-third is membrane bound (32 (19) were unable to clone an EcoRI fragment containing a highly expressed allele of penP into the EcoRI site of pUB110 (i.e., no Bla+ colonies were detected among Kmr transformants). However, the same fragment could be cloned into a low-copy-number plasmid vector. In contrast to the behavior of this highly expressed allele, an allele of penP that was not so highly expressed could be cloned into either vector. Several analogous examples of restriction fragments that cannot be cloned on high copy number vectors, but that can be cloned on lower-copynumber vectors, have been reported in E. coli (15, 16, 27 ).
These results suggest that both the degree of expression of the gene being cloned and the nature of the vector being used can play a role in whether a cloned gene will be successfully established in a particular host on a particular vector. In the case of blaZ, we cannot determine at present whether the failure to be established on plasmids in B. subtilis is due to some toxic effect(s) of a product of the cloned DNA, to disruption of some essential plasmid function as a result of the presence of the cloned insert, or to some other cause. However, any interpretation will need to account for the fact that neither the intact blaZ gene (on pGX312 and pGX314) nor a small fragment from the 5' end (on pGX318) could be established.
Chromosomal integration vectors have been previously used in B. subtilis to map genes for which there is no selectable marker (14, 47) or for complementation analysis (7) . In this paper, we have demonstrated the additional value of such vectors in the stabilization of a highly expressed gene. Although existing low-copy-number plasmid vectors may also be useful for this purpose (19) (Fig. 3) , it is likely that the IS] insertion into pGX318 occurred in E. coli. First, there appear to be no IS] sequences in B. subtilis (33) . Second, when the DNA preparation (from E. coli) used in the transformation from which pGX2427 had been recovered was examined carefully, it was found to be a mixture of pGX318 and a small amount of pGX318::ISI. The latter was apparently identical to pGX2427. We have observed several independent IS] insertions into blaZ segments in E. coli (data not shown) in addition to that described in pGX2427.
Although we have not sequenced the IS] insertion site in any of these cases, the target sites for IS] have been reported to be AT rich (28) . The blaZ promoter, like many other promoters from gram-positive bacteria (29) , is very AT rich (25) . Thus, IS] insertion into such promoters may not be an infrequent event during work with genes of gram-positive bacterial origin in E. coli.
